Stockscreener 앱 받기
7.45
1.84%
-0.14
Cybin Inc 주식(CYBN)의 최신 뉴스
Cybin gains Irish Medicines Board approval for major depressive disorder trial - Yahoo Finance
Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - BioSpace
Cybin Inc. shares rise 1.13% intraday after receiving approval to initiate EMBRACE trial in Europe. - AInvest
Psychedelic: Cybin receives European approval for EMBRACE study - TipRanks
Cybin receives European approval for EMBRACE trial - TipRanks
Cybin Gets European Approval For EMBRACE Study Of CYB003 For Major Depressive Disorder - Nasdaq
Cybin Secures European Approval for EMBRACE Study in Major Depressive Disorder - TipRanks
Cybin receives European approval for phase 3 depression drug trial By Investing.com - Investing.com Nigeria
Cybin receives European approval for phase 3 depression drug trial - Investing.com
Breakthrough Depression Drug Shows 71% Remission Rate as Phase 3 Trial Expands to Europe - Stock Titan
Cybin CEO to Speak at Canaccord Genuity Growth Conference - TipRanks
Cybin to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
What are the latest earnings results for Cybin Inc.Achieve rapid wealth accumulation through smart investing - Jammu Links News
Cybin Inc. Stock Analysis and ForecastFree Market Dynamics Reports - Jammu Links News
How volatile is Cybin Inc. stock compared to the marketCapitalize on emerging investment opportunities - Jammu Links News
What institutional investors are buying Cybin Inc. stockCapitalize on market trends before they peak - Jammu Links News
What are analysts’ price targets for Cybin Inc. in the next 12 monthsUnlock powerful market analysis and alerts - Jammu Links News
Is Cybin Inc. stock overvalued or undervaluedUnstoppable trading performance - Jammu Links News
How many analysts rate Cybin Inc. as a “Buy”Achieve consistent profits with proven methods - Jammu Links News
Is Cybin Inc. a good long term investmentSuperior profit margins - Jammu Links News
When is Cybin Inc. stock expected to show significant growthAchieve breakthrough financial results - Jammu Links News
Why is Cybin Inc. stock attracting strong analyst attentionInvest smarter with data-backed trading alerts - Jammu Links News
What are Cybin Inc. company’s key revenue driversGet expert insights on market-moving stocks - Jammu Links News
Cybin Announces $1 Billion Mixed Securities Shelf Filing to Enhance Financial Flexibility - AInvest
Cybin Inc. Schedules Virtual Annual General Meeting for August 2025 - MSN
Cybin Inc. May Be Forming Higher Low — Chartwatchers AlertFundamental + Technical Hybrid Stock Tips Shared - beatles.ru
Should I hold or sell Cybin Inc. stock in 2025Real Time Insights For 2025 - jammulinksnews.com
What is the dividend policy of Cybin Inc. stockFree Risk Assessment Services - Jammu Links News
What are the technical indicators suggesting about Cybin Inc.Access high-yield investment alerts now - Jammu Links News
How Cybin Inc. stock performs during market volatilitySolid Return Trade Selections - metal.it
What analysts say about Cybin Inc. stockSuperior portfolio returns - PrintWeekIndia
Cybin, Inc: CYB003 Vs. GH001Duration, Durability and Protocol Execution - Smartkarma
What drives Cybin Inc. stock pricePowerful market insights - PrintWeekIndia
Will Cybin Inc. stock benefit from AI tech trendsFree Predictions - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):